Pharmafile Logo
Pharmafocus logo
Advanced Search

UK

Showing 15 posts of 472 posts found.

doctor-563428_960_720

100,000 vacancies contribute to NHS crisis

December 19, 2017
Manufacturing and Production, Medical Communications NHS, UK, biotech, drugs, nurses, pharma, pharmaceutical

Warning shots have been fired by both the General Medical Council (GMC) and the Labour Party about the recruitment issues …

News
novartis_window

Novartis nets first acute myeloid leukaemia approval in Canada, but NICE says no

December 6, 2017
Research and Development, Sales and Marketing Canada, NICE, Novartis, Rydapt, UK, acute myeloid leukaemia, leukaemia, pharma

Novartis is celebrating the news that its drug Rydapt (midostaurin) has been awarded marketing approval in Canada for the treatment …

News
care_old

UK austerity measures to social care led to 120,000 deaths

November 17, 2017
Medical Communications UK, austerity, biotech, drugs, pharma, pharmaceutical, social care

A new study has claimed that austerity measures introduced since 2010 are linked to 120,000 deaths across England. The research …

News
seqirus_08-11-17_full-42_003_web

Seqirus announces £40m UK fill-and-finish flu vaccine facility

November 9, 2017
Manufacturing and Production Liverppol, Novartis, UK, Vaccine, flu, influenza, pharma, seqirus

Seqirus, an influenza vaccine specialist subsidiary of global biotech firm CSL, has announced a £40 million investment into a new …

News

Measles eradicated in the UK, according to WHO

September 28, 2017
Medical Communications UK, WHO, biotech, drugs, measles, pharma, pharmaceutical

The measles virus has been eliminated from the UK for the first time in the country’s history, according to the …

News
brexit_flag_0

UK’s post-Brexit strategy looks to life sciences industry

August 30, 2017
Medical Communications, Research and Development UK, biotech, brexit, drugs, life sciences, pharma, pharmaceutical

The UK Government had already announced, as part of its industrial plan, that the life sciences were regarded as a …

News
astrazeneca-sign

AstraZeneca invests “tens of millions” into Cheshire, UK manufacturing site

August 29, 2017
Manufacturing and Production, Research and Development AZ, AstraZeneca, Cheshire, Chesire, UK, life sciences, pharma, pharmaceuticals

AstraZeneca has announced plans to invest a multi-million sum into its £150 million facility in Macclesfield, Chesire, UK – a …

News
old-peoples-home-524234_960_720

Massive increase in UK care home places needed by 2025, report finds

August 16, 2017
Research and Development UK, UK government, biotech, drugs, pharma, pharmaceutical, social care

A study emerging from Newcastle University has pointed towards a potential crisis in care home places by 2025, as a …

News
gsk_ulverston_plant_impression

GSK continues restructure by axing £350m Cumbria plant plans

July 21, 2017
Manufacturing and Production, Medical Communications GSK, GlaxoSmithKline, UK, biotech, drugs, pharma, pharmaceuticals

Just days after UK pharma giant GSK announced it would be selling off its Horlicks brand to focus on its …

News
brexit-referendum-uk-1468255193y2p

What pharma should know about the European Unitary Patent in light of Brexit

July 17, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, biotech, brexit, drugs, healthcare, pharma, pharmaceutical

The departure of the United Kingdom from the European Union, dubbed “Brexit,” has sparked significant economic global uncertainty. Two Brexit-related …

Feature
brexit

UK and EU life sciences demand closer collaboration in joint letter to Brexit negotiators

July 13, 2017
Sales and Marketing EU, UK, biotech, brexit, drugs, life sciences, pharma, pharmacuetical

The pharmaceutical and life sciences industries have stressed the importance of cooperation between the EU and the UK in order …

News
brexit_flag

European pharma pulls together to ensure ‘minimal disruption’ from Brexit

July 10, 2017
Research and Development, Sales and Marketing EMA, Europe, UK

As a consequence of the triggering of Article 50 and the UK’s exit from the EU, the EMA – currently …

News
640px-palace_of_westminster_at_night

What the life sciences industry wants from the next UK government

June 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA, UK, general election, life sciences

The stakes are high as the UK general election draws ever closer, and the industry has come out in force …

Feature
shutterstock_46732501

Could robots solve the pharma talent crisis?

May 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, UK, brexit, pharma, talent crisis

Unpredictability in the industry and beyond is rife, but talent acquisition remains a key issue for Pharma and Life Sciences. …

Feature
pharmafocus_june_2017_cover

The June 2017 issue of Pharmafocus is now live!

May 23, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Pharmafocus, Roche, Takeda, UK, brexit, data management, market access, neurological disorders

The latest edition of Pharmafocus is available to read online now!

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026